Metabolic syndrome by the international diabetes federation definition in Hong Kong Chinese

Diabetes Research and Clinical Practice

Volumn 73, Issue 1, 2006, Pages 58-64

  Ko, G T C ^a   Cockram, C S ^b   Chow, C C ^b   Yeung, V T F ^c   Chan, W B ^d   So, W Y ^b   Chan, N N ^d   Chan, J C N ^b  

^a AH Nethersole Hospital   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c Our Lady of Maryknoll Hospital   (Hong Kong)

^d Qualigenics Diabetes Centre   (Hong Kong)

Author keywords

Chinese; Diagnostic criteria; International Diabetes Federation; Metabolic syndrome

Indexed keywords

TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHINESE; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HONG KONG; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METABOLIC SYNDROME X; PREVALENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HONG KONG; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE;

EID: 33747081437     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2005.11.009     Document Type: Article

References (31)

1. Malik S., Wong N.D., Franklin S.S., Kamath T.V., L'Italien G.J., Pio J.R., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110 (2004) 1245-1250
2. Hu G., Qiao Q., Tuomilehto J., Balkau B., Borch-Johnsen K., Pyorala K., and DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch. Intern. Med. 164 (2004) 1066-1076
3. Hunt K.J., Resendez R.G., Williams K., Haffner S.M., Stern M.P., and San Antonio Heart Study. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110 (2004) 1251-1257
4. Alberti K.G., Zimmet P.Z., and for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diab. Med. 15 (1998) 539-553
5. Balkau B., and Charles M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diab. Med. 16 (1999) 442-443
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
7. Lebovitz H.E. The relationship of obesity to the metabolic syndrome. Int. J. Clin. Pract. Suppl. 134 (2003) 18-27
8. Bosello O., and Zamboni M. Visceral obesity and metabolic syndrome. Obes. Rev. 1 (2000) 47-56
9. Bjorntorp P. Abdominal obesity and the metabolic syndrome. Ann. Med. 24 (1992) 465-468
10. Carr D.B., Utzschneider K.M., Hull R.L., Kodama K., Retzlaff B.M., Brunzell J.D., et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53 (2004) 2087-2094
11. Anderson P.J., Critchley J.A., Chan J.C., Cockram C.S., Lee Z.C., Thomas G.N., et al. Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. Int. J. Obes Relat. Metab. Disord. 25 (2001) 1782-1788
12. WHO Expert Consultation. Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363 (2004) 157-163
13. Yajnik C.S., and Yudkin J.S. The Y-Y paradox. Lancet 363 (2004) 163
14. Deurenberg P., Deurenbery-Yap M., and Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes. Rev. 3 (2002) 141-146
15. Ko G.T., Tang J., Chan J.C., Sung R., Wu M.M., Wai H.P., et al. Lower body mass index cut-off to define obesity in Hong Kong Chinese: an analysis based on body fat assessment by bioelectrical impedance. Br. J. Clin. Nutr. 85 (2001) 239-242
16. International Diabetes Federation, The IDF consensus worldwide definition of the metabolic syndrome, http://www.idf.org/webdata/docs/IDF Metabolic syndrome definition.pdf.
17. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diab. Care 26 (2003) 3160-3167
18. Ko G.T., Cockram C.S., Chow C.C., Yeung V., Chan W.B., So W.Y., et al. High prevalence of metabolic syndrome in Hong Kong Chinese-comparison of three diagnostic criteria. Diab. Res. Clin. Pract. 69 (2005) 160-168
19. Ko G.T., Chan J.C., Cockram C.S., and Woo J. Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese. Int. J. Obes. Relat. Metab. Disord. 23 (1999) 1136-1142
20. Friedewald W.T., Levy R.I., and Fredrickason D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
21. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and β-cell function from fasting blood glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
22. Mogensen C.E., Vestbo E., Poulsen P.L., Christiansen C., Damsgaard E.M., Eiskjaer H., et al. Microalbuminuria and potential confounders. Diab. Care 18 (1985) 572-581
23. Hospital Authority, Hospital Authority Statistical Report 2000-2001, Hong Kong, 2002.
24. G.T. Ko, W.Y. So, N.N. Chan, W.B. Chan, P.C. Tong, J. Li, et al., The WHO but not NCEP definition for the metabolic syndrome predicts cardiovascular and total mortality in Chinese Type 2 diabetic patients, Diab. Obes. Metab., in press.
25. Ng M.C., So W.Y., Lam V.K., Cockram C.S., Bell G.I., Cox N.J., et al. Genome-wide scan for metabolic syndrome and related quantitative traits in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-q25. Diabetes 53 (2004) 2676-2683
26. J.K. Li, M.C. Ng, W.Y. So, C.K. Chiu, R. Ozaki, P.C. Tong, et al., Phenotypic and genetic clustering of diabetes and metabolic syndrome in Chinese families with type 2 diabetes mellitus, Diab. Metab. Res. Rev. (2005) (Epub ahead of print).
27. Chan J.C., Cheung J.C., Stehouwer C.D., Emeis J.J., Tong P.C., Ko G.T., et al. The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the metabolic syndrome-an analysis by structural equation modelling. Int. J. Obes. Relat. Metab. Disord. 26 (2002) 994-1008
28. Ford E.S. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diab. Care 28 (2005) 2745-2749
29. Lemieux I., Pascot A., Couillard C., Lamarche B., Tchernof A., Almeras N., et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?. Circulation 102 (2000) 179-184
30. Liu K.H., Chan Y.L., Chan W.B., Kong W.L., Kong M.O., and Chan J.C. Sonographic measurement of mesenteric fat thickness is a good correlate with cardiovascular risk factors: comparison with subcutaneous and preperitoneal fat thickness, magnetic resonance imaging and anthropometric indexes. Int. J. Obes. Relat. Metab. Disord. 27 (2003) 1267-1273
31. Liu K.H., Chan Y.L., Chan J.C., and Chan W.B. Association of carotid intima-media thickness with mesenteric, preperitoneal and subcutaneous fat thickness. Atherosclerosis 179 (2005) 299-304